Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Shares Issued: 2009-2024

Historic Shares Issued for Myriad Genetics (MYGN) over the last 13 years, with Dec 2024 value amounting to $2.9 million.

  • Myriad Genetics' Shares Issued fell 97.53% to $2.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $123.8 million, marking a year-over-year increase of 0.16%. This contributed to the annual value of $5.9 million for FY2024, which is 94.98% down from last year.
  • Latest data reveals that Myriad Genetics reported Shares Issued of $2.9 million as of Q4 2024, which was down 97.53% from $117.6 million recorded in Q4 2023.
  • Myriad Genetics' 5-year Shares Issued high stood at $117.6 million for Q4 2023, and its period low was $300,000 during Q1 2020.
  • For the 3-year period, Myriad Genetics' Shares Issued averaged around $21.1 million, with its median value being $2.5 million (2022).
  • In the last 5 years, Myriad Genetics' Shares Issued skyrocketed by 8,733.33% in 2021 and then tumbled by 98.87% in 2022.
  • Quarterly analysis of 5 years shows Myriad Genetics' Shares Issued stood at $1.8 million in 2020, then remained steady at $1.8 million in 2021, then skyrocketed by 33.33% to $2.4 million in 2022, then skyrocketed by 4,800.00% to $117.6 million in 2023, then tumbled by 97.53% to $2.9 million in 2024.
  • Its Shares Issued was $2.9 million in Q4 2024, compared to $117.6 million in Q4 2023 and $2.4 million in Q4 2022.